COVID-19 hospitalizing more children, raising new worries about resources

Pediatric hospitalizations for COVID-19 are on the rise around the U.S. And although the rate of increase varies widely by state, researchers tracking the trend are concerned about shortfalls in transferable resources when case spikes occur.

The researchers, from the University of Minnesota, had their findings published in JAMA Pediatrics this month.

Drawing data from their institution’s pandemic tracking project, Pinar Karaca-Mandic, PhD, and colleagues analyzed COVID hospitalizations in 22 states that reported cumulative overall admissions and cumulative pediatric admissions per 100,000 persons between mid-May and mid-November.

They found the most alarming single percentage increase during that timeframe belonged to Utah. The Beehive State saw a 5,067% jump in pediatric COVID admissions.

Similarly, Arizona’s pediatric COVID hospitalizations swelled 4,000%.

Nationally, the researchers found, the average increase was 760% (from 2.0 pediatric hospitalizations per 100,000 persons in May to 17.2 in November).

No state in the study saw a decrease in pediatric hospitalizations for COVID.

Karaca-Mandic and co-authors note their reliance on data from only 22 states as a limitation in their study design. This weakness was offset, they suggest, by the studied states representing a collective population of 29 million children.

“Adult, and especially geriatric, incidence of COVID-19 continues to dominate the national picture, but pediatric populations may require resources that are not readily available across the country,” the authors comment.

“As conversations around in-person education continue,” they add, “hospitalization growth may offer reasons for concern.”

In coverage of the research by a Fox TV affiliate in Arizona, a family-medicine physician underscores the need for watchfulness around local returns in-person schooling—especially while new COVID variants are spreading.

“I know from reports from my pediatric colleagues that they are starting to see their hospitals get pretty overwhelmed with children with COVID,” Andrew Carroll, MD, tells the station. “When you have something that is just so darn contagious go up by about 50%, those people that thought they couldn’t get sick, those people are getting sick now.”

Research paper here, TV news report here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.